Le Lézard
Classified in: Covid-19 virus
Subject: Product/Service

Best's Market Segment Report: AM Best Assigns Stable Outlook to Malaysia's Non-Life Insurance Industry


AM Best has assigned a stable market segment outlook to Malaysia's non-life insurance industry, based on the sector's underwriting discipline and robust pricing, as well as increased use of digital solutions to enhance data and pricing capabilities, claims automation, product innovation and distribution.

In its Best's Market Segment Report, "Market Segment Outlook: Malaysia Non-Life Insurance," AM Best states the economic fallout from COVID-19 is expected to remain a key challenge for the Southeast Asian country's non-life segment for at least the near term. A slight contraction in non-life insurance premiums was offset partially by growth in health insurance, as the pandemic boosted demand and raised awareness for health and medical products. Looking ahead, AM Best expects the health line of business to remain an important driver of the non-life industry's growth.

Economic recovery likely will be affected adversely by the need to impose periods of stricter COVID-19 containment measures, such as those seen in May, June and July 2021. Furthermore, the effectiveness of the country's COVID-19 vaccination programme will be instrumental in allowing the country to open up more freely over the months ahead.

According to the report, Malaysia's non-life market has made good progress in upgrading its infrastructure to enable minimal disruption in a remote working environment, as well as in expanding digital platforms to manage operations. AM Best notes that most insurance companies now have an established framework and developed risk management guidelines to govern a digital-based remote working environment during periods of movement control orders with business contingency plans set up.

AM Best notes that capital market volatility remains a risk over the near term and is likely to be dependent on ongoing global and regional developments, as well as management of the pandemic. In response to these market conditions, AM Best expects the segment's non-life insurers to continue to closely monitor their underlying risk exposure to various investment classes and adjust and refine their portfolio allocation as part of their risk management approach.

To access the full copy of this market segment report visit http://www3.ambest.com/bestweek/purchase.asp?record_code=311223.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.


These press releases may also interest you

at 16:36
The University of Kansas Medical Center partnered with the KU Edwards Campus to launch an online generalist concentration for the Master of Public Health degree and certificates in essentials of public health, epidemiology, and public health...

at 16:35
DXC Technology Company ("DXC") today announced the completion of its refinancing. DXC previously completed the offering of ?1.35 billion Senior Notes priced on September 2, 2021 and $1.35 billion Senior Notes priced on September 7, 2021. DXC...

at 16:30
The "India Post COVID Health Tests Market, FY2027" report has been added to ResearchAndMarkets.com's offering. India post COVID health tests market is anticipated to grow with an impressive CAGR in the forecast period, FY2023-FY2027 The market is...

at 16:30
Rafael Holdings, Inc., , a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its Barer Institute and investment in Rafael Pharmaceuticals, Inc., announced today the appointment of Ashok Marin, Chief...

at 16:20
Magnolia Oil & Gas Corporation ("Magnolia" or the "Company") today announced the pricing of the previously announced underwritten block trade of 7,500,000 shares of the Company's Class A common stock (the "Class A Common Stock") by certain...

at 16:15
The "Global Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report by Product (Vials, Bottles, Cartridges & Syringes, Ampoules), by Drug Type (Generic, Branded, Biologic), by Region, and Segment Forecasts, 2021-2028" report has...



News published on 1 august 2021 at 20:05 and distributed by: